J. Biol. Chem., Vol. 261, Issue 2, 752-757, Jan, 1986
Regulation of epidermal growth factor receptor number and phosphorylation by fasting in rat liver
GR Freidenberg, HH Klein, MP Kladde, R Cordera and JM Olefsky
The binding of 125I-epidermal growth factor (EGF) to microsomal membrane
preparations from the livers of rats fasted for 72 h or fed control or high
carbohydrate diets was examined to determine whether alterations in
nutrient intake could affect the EGF receptor system. Fasted rats had
40-50% less membrane binding than did control or carbohydrate-fed rats.
Scatchard analysis of the binding data indicated that the decrease in EGF
binding in fasted rats was due to a decrease in receptor number with no
change in receptor affinity. Cross-linking of 125I-EGF to EGF receptors
with disuccinimidyl suberate revealed specific binding of a Mr 170,000
protein, which was diminished by approximately 75% in fasting, and a Mr =
150,000 protein, which accounted for 40-50% of the total labeling in the
control and carbohydrate-fed rats and which was relatively unchanged by
fasting. The sum of the labeling of the 2 bands was reduced by
approximately 40% in fasting and is consistent with the reduction in EGF
binding detected by Scatchard analysis. EGF stimulated a 1.5-3-fold
increase in 32P incorporation into one major protein of 170 kDa in all 3
groups. Basal and EGF-stimulated autophosphorylation of 170 kDa, when
normalized for protein, was 75% lower in membranes from fasted animals,
compared to those from control or carbohydrate-fed rats. The comparable
reduction of 125I-EGF binding to, and 32P incorporation into, the 170-kDa
EGF receptor protein suggested that kinase activity/receptor was unaffected
by fasting. Moreover, EGF receptor kinase activity in the 3 groups was
comparable for an exogenous substrate, as judged by equal basal and EGF-
stimulated phosphorylation of Val5-angiotensin II, when normalized for
total EGF-binding capacity. These results suggest that fasting regulates
EGF receptor kinase activity primarily by regulation of the number of
hepatic EGF receptors. The possibility exists that some in vivo effects of
fasting may be mediated by a reduction in EGF receptor levels.